CytoMed Therapeutics Ltd - Ordinary Shares (GDTC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
GDTC on Nasdaq
Shares outstanding
11,735,810
Price per share
$0.95
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
53,128
Total reported value
$70,777
% of total 13F portfolios
0%
Share change
+35,004
Value change
+$43,411
Number of holders
5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CytoMed Therapeutics Ltd - Ordinary Shares (GDTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Choo Chee Kong 22% -4.9% $5,046,105 -$166,879 2,587,746 -3.2% Choo Chee Kong 29 Oct 2025
mDR Ltd 11% $3,112,881 1,307,933 mDR LTD 16 Dec 2024
28 Consultants Ltd 7.6% $2,095,145 880,313 28 Consultants Ltd 17 Feb 2025

As of 31 Dec 2025, 5 institutional investors reported holding 53,128 shares of CytoMed Therapeutics Ltd - Ordinary Shares (GDTC). This represents 0.45% of the company’s total 11,735,810 outstanding shares.

Institutional Holders of CytoMed Therapeutics Ltd - Ordinary Shares (GDTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 53,128 $70,777 +$43,411 $1.34 5
2025 Q3 18,124 $36,067 -$57,854 $1.99 2
2025 Q2 45,250 $98,493 +$29,244 $2.19 2
2025 Q1 31,697 $70,308 +$48,294 $2.22 2
2024 Q4 10,098 $34,333 +$34,126 $3.40 1
2024 Q3 61 $96 +$96 $1.57 1
2024 Q2 0 $0 -$28 $0.95 0
2024 Q1 13 $28 -$19,022 $2.15 1
2023 Q4 4,382 $21,472 +$135 $4.90 2
2023 Q3 5,884 $20,670 +$20,481 $3.51 2
2023 Q2 54 $165 +$165 $3.06 1